-transparent.png){kind=logo}
In this paper a method for the radioimmunological determination of triamcinolone acetonide (TAAc) in plasma is described. The antiserum used in the radioimmunological determinations showed high specifity for TAAc; the minimal detectable amount was 0.2 ng. The course of the plasma concentration-time curve of TAAc after intravenous injection into rats was analysed. The concentration of TAAc in the blood of the patients after topical application of the drug is very low. No detectable amount of TAAc was found in the blood of out-patients. Hospitalized patients treated with TAAc under plastic occlusion showed plasma levels ranging from 0.8 to 3.4 ng/ml. This level remained constant throughout the treatment.
M Ponec, and
M Frölich, and
A de Lijster, and
A J Moolenaar
May 1980,
European journal of clinical pharmacology,
M Ponec, and
M Frölich, and
A de Lijster, and
A J Moolenaar
March 1962,
El Dia medico,
M Ponec, and
M Frölich, and
A de Lijster, and
A J Moolenaar
December 1983,
Journal of pharmaceutical sciences,
M Ponec, and
M Frölich, and
A de Lijster, and
A J Moolenaar
October 2006,
Archives of dermatological research,
M Ponec, and
M Frölich, and
A de Lijster, and
A J Moolenaar
July 1965,
The Journal of the Maine Medical Association,
M Ponec, and
M Frölich, and
A de Lijster, and
A J Moolenaar
August 1980,
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
M Ponec, and
M Frölich, and
A de Lijster, and
A J Moolenaar
September 1982,
Berliner und Munchener tierarztliche Wochenschrift,
M Ponec, and
M Frölich, and
A de Lijster, and
A J Moolenaar
June 2004,
American journal of ophthalmology,
M Ponec, and
M Frölich, and
A de Lijster, and
A J Moolenaar
June 1971,
Metabolism: clinical and experimental,
M Ponec, and
M Frölich, and
A de Lijster, and
A J Moolenaar
May 1974,
American journal of obstetrics and gynecology,
